Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - ALBIREO PHARMA, INC. | albo-20180930ex3124b9cd7.htm |
| EX-31.1 - EX-31.1 - ALBIREO PHARMA, INC. | albo-20180930ex3117f4139.htm |
| EX-10.6 - EX-10.6 - ALBIREO PHARMA, INC. | albo-20180930ex1065bbd17.htm |
| EX-10.5 - EX-10.5 - ALBIREO PHARMA, INC. | albo-20180930ex105e4f35b.htm |
| EX-10.4 - EX-10.4 - ALBIREO PHARMA, INC. | albo-20180930ex1045fc5f7.htm |
| EX-10.3 - EX-10.3 - ALBIREO PHARMA, INC. | albo-20180930ex103f51226.htm |
| EX-10.2 - EX-10.2 - ALBIREO PHARMA, INC. | albo-20180930ex1023a0668.htm |
| EX-10.1 - EX-10.1 - ALBIREO PHARMA, INC. | albo-20180930ex101f10f17.htm |
| 10-Q - 10-Q - ALBIREO PHARMA, INC. | albo-20180930x10q.htm |
Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Albireo Pharma, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report for the quarter ended September 30, 2018 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: November 8, 2018 |
|
/s/ Ronald H.W. Cooper |
|
|
|
Ronald H.W. Cooper |
|
|
|
President and Chief Executive Officer |
|
|
|
(principal executive officer) |
|
Dated: November 8, 2018 |
|
/s/ Simon Harford |
|
|
|
Simon N.R. Harford |
|
|
|
Chief Financial Officer and Treasurer |
|
|
|
(principal financial officer and principal accounting officer) |